Dumaguete Info Search


Worlds first dengue vaccine approved

Discussion in 'News and Weather' started by DavyL200, Dec 13, 2015.

  1. DavyL200

    DavyL200 DI Forum Luminary ★ Global Mod ★ ★ Moderator ★ Highly Rated Poster Showcase Reviewer

    Messages:
    3,968
    Trophy Points:
    401
    Location:
    On an island
    Ratings:
    +5,126 / 466
    Sanofi's dengue vaccine is to make its market debut in Mexico, the French drugmaker said on Wednesday, adding that it expects to have filed for market approval in some 20 countries by year-end.

    Sanofi Pasteur, the group's vaccines division, said Mexico had approved the preventive treatment, called Dengvaxia, for all four dengue virus serotypes, but only for patients aged 9 to 45 who live in areas where the disease is endemic.

    This means the world's first dengue vaccine has no approval yet for use on young children, a population considered to be most at risk, or for use by tourists.

    Dengue fever is a mosquito-borne disease caused by four virus serotypes (1 to 4) as categorized by the World Health Organisation. Overall, the disease is seen as a threat to about half of the world's population. Some 400 million people are believed to be infected annually.

    Guillaume Leroy, who leads the dengue team at Sanofi Pasteur, said the vaccine acted best as an immune booster for patients with some previous exposure.

    He told Reuters in an interview that additional data over the coming years would be needed to assess whether the vaccine may be of use to travelers.

    "Health authorities will have to determine (future) recommendations," he said, adding Sanofi's first 20 market approval requests were all in South America and Asia. Europe is the target for early next year and the United States in early 2017


    Read more at Reutershttp://Sanofi wins first dengue vaccine market approval in Mexico| Reuters
     
    • Like Like x 4
  2. Cerne

    Cerne DI Forum Adept

    Messages:
    426
    Trophy Points:
    211
    Ratings:
    +538 / 199
    Interesting stuff and good news for all....eventually when the patent runs out and the generics become available.

    The genetic modifying of mosquito's is also an initiative that might give relief for malaria and other diseases. When I explained genetic modification of lamoks to the good lady wife her brows furrowed. Normally one of the brightest buttons in the sewing box a momentary lapse occurred: she explained that it would cost a lot of money to capture all the lamoks in the Phils and force them to breed, and what if they were not in the mood? Or that didn't like the cut of the genetically modified lamoks to breed with them? How were scientists going to sex the lamoks and make sure boy meets girl etc.

    I give in...
     
    • Funny Funny x 4
  3. OP
    OP
    DavyL200

    DavyL200 DI Forum Luminary ★ Global Mod ★ ★ Moderator ★ Highly Rated Poster Showcase Reviewer

    Messages:
    3,968
    Trophy Points:
    401
    Location:
    On an island
    Ratings:
    +5,126 / 466
    The worlds first dengue vaccine will be approved for use in the country by the end of the year, making the Philippines the second country to make it available in the market next to Mexico, according to the Department of Health (DOH).

    Health Secretary Janette Garin disclosed that the Food and Drug Administration (FDA) was on the last phase of deliberations in approving the use of Dengvaxia, which was developed by French pharmaceutical company Sanofi.

    “We had a meeting with FDA and they are wrapping up the review. After the approval, this means it will now be available for the private sector,” said Garin in a recent interview. “We are looking to issue the FDA approval before the end of the year,” she said.

    Garin had expected the Philippines to be the first country to give the green light to the sale and use of the dengue vaccine.

    But on Dec. 9, Mexico granted marketing authorization to the vaccine, which will curb the spread of the disease caused by all four dengue virus stereotypes in children and adults residing in endemic areas.

    Dengue is endemic in the Philippines, where about 100,000 people get infected yearly and hundreds die due to the virus.

    From January to October this year alone, the DOH has recorded 108,263 dengue cases nationwide, with 31.8 percent aged 5 to 14 years old. More than 300 deaths have also been reported during this period.

    But with the vaccine, the DOH is hoping to significantly bring down the number of infections and deaths.



    Read more: Anti-dengue vaccine sold in PH by year-end | Inquirer News
    Follow us: @inquirerdotnet on Twitter | inquirerdotnet on Facebook
     
    • Informative Informative x 1
Loading...